Drug tolerant persister cells of EGFR-mutant cell line under kinase-inhibitor combination
Ontology highlight
ABSTRACT: Drug tolerant persister cells of EGFR-mutant PC9 cell lines surviving treatment with kinase inhibitor combination. Cells were treated with combination of erlotinib, osimertinib, trametinib and dasatinib and surviving cells were harvested for RNA extraction. 3' UTR RNA-seq profiles were compared to parental control cells and to outgrowing cells after treatment had been removed
INSTRUMENT(S): Illumina HiSeq 4000
ORGANISM(S): Homo sapiens
SUBMITTER: Johannes Braegelmann
PROVIDER: E-MTAB-13045 | biostudies-arrayexpress |
REPOSITORIES: biostudies-arrayexpress
ACCESS DATA